Tracking Trump's visits to his properties and other conflicts of interest

When “Pharma bro” Martin Shkreli testifies before Congress this morning to talk about the pharmaceutical price gouging he was involved in at Turing Pharmaceuticals, it will be hard for him to avoid questions about his recent arrest on securities fraud charges.

Over the last several months, CREW's old foe Martin Shkreli has become a household name after he acquired the rights to an obscure drug, and jacked up the price more than 5,000 percent.